Clinical Trials Directory

Trials / Completed

CompletedNCT02210936

SCOSI-M: Preventing Prescription Drug Problems

Preventing Prescription Drug Problems: A Pilot Military Opioid Safety Initiative

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
93 (actual)
Sponsor
Brandeis University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

Brandeis University and University of South Carolina (USC) have joined together to develop the South Carolina Opioid Safety Initiative - Military (SCOSI-M), to develop an academic detailing (medical education) intervention for physicians and evaluate its effectiveness in a pilot study. The goal of the intervention is to increase the use of safe prescribing and prescription monitoring practices among primary care physicians. The research team will design and pilot an educational intervention for physicians who treat military personnel, veterans, and their families with prescription opioids. The overall aim of SCOSI-M is to prevent the onset or progression of prescription drug problems among Iraq and Afghanistan veterans, military members, and their families who are at high risk for developing problems if their treatment involves long-term use of an opioid.

Conditions

Interventions

TypeNameDescription
OTHEREducational InterventionThe design is primarily a pre-post, non-equivalent comparison group test of program effectiveness. If final sample size permits, we will examine program effects for each practice environment separately. For measures that require interview data there will be no comparison group data. We will construct matched comparison groups of physicians for each environment for which only secondary data analysis will be conducted. The matched comparison group will be constructed using prescription data from the DoD's pharmacy data transaction system (MACH and DORN VAMC) and from SCRIPTS (community-based physicians and VA prescribers).

Timeline

Start date
2014-07-01
Primary completion
2019-05-01
Completion
2019-05-01
First posted
2014-08-07
Last updated
2020-07-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02210936. Inclusion in this directory is not an endorsement.